NCT00322322View on ClinicalTrials.gov

Early Administration of L-carnitine in Hemodialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Complication of HemodialysisHyperthyroidism Treated or Under Control
Interventions
DRUG

L-Carnitine

L-Carnitine

Trial Locations (2)

75004

Assistance Publique Hopitaux de Paris, Paris

75013

HOPITAL LA PITIE SALPETRIERE, service de Néphrologie, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00322322 - Early Administration of L-carnitine in Hemodialysis Patients | Biotech Hunter | Biotech Hunter